Financials
- Market Capitalization 88.28 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.19
Fiyat/satışlar oranı
464.04
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3987 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.49 USD | -3.25% | -2.61% | -8.59% | -74.40% | 89.89 M USD | ||
| 3994 | RLYB Rallybio Corporation - Common Stock | 16.81 USD | +0.30% | +1.63% | +5.66% | +3132.69% | 89.27 M USD | ||
| 4003 | OKYO OKYO Pharma Limited - American Depositary Shares | 1.67 USD | +7.74% | +7.74% | +2.45% | -28.33% | 87.64 M USD | ||
| 4011 | LNAI Lunai Bioworks Inc. - Common Stock | 2.37 USD | +0.85% | +9.72% | +15.05% | +52.90% | 85.96 M USD |